ArticleBMC psychology2026
Screen-detected cognitive impairment, psychological distress, and quality of life in cancer patients undergoing chemotherapy in Yemen.
Article in BMC psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic potential and mechanisms of rehabilitation interventions in preventing cancer metastasis.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer care in Yemen faces limited data and resources. Chemotherapy may cause cognitive, psychological, and quality-of-life complications. This study assesses the prevalence of screen-positive cognitive impairment (based on MoCA screening), anxiety, depression, and quality-of-life outcomes, as well as their associated factors, among Yemeni patients.
methodsA cross-sectional study was conducted in June-July 2025 at the National Oncology Center, Sana'a, involving adult cancer patients receiving chemotherapy. Cognitive function (MoCA), anxiety/depression (HADS), and quality of life (SF-12) were assessed via structured interviews, and data were analyzed using descriptive statistics and multiple regression (SPSS v28, p < 0.05).
resultsAmong 167 patients, most were male (64.7%), married (83.8%), and in advanced cancer stages (81.3%). Only 6% had normal cognition, while 94% demonstrated screen-positive cognitive impairment, particularly in language and visuospatial domains. Borderline or abnormal anxiety and depression were observed in approximately 20% of patients. Mean PCS-12 (40.4) and MCS-12 (43.2) scores indicated reduced health-related quality of life. In multivariable regression, the cognitive model was significant and explained 41.7% of the variance (adjusted R² = 0.417). Older age (B = - 2.39), male sex (B = - 3.43), and smoking (B = - 1.42) were associated with lower cognition, whereas higher education was positively associated (B = 2.34). The PCS-12 and MCS-12 models explained 11.6% (adjusted R² = 0.046) and 10.0% (adjusted R² = 0.028) of the variance but were not significant overall. Higher education (B = 1.49) and smoking (B = - 2.44) were associated with physical health, while employment (B = 3.71) and metastasis (B = 3.41) were associated with mental health.
conclusionCognitive, psychological, and quality-of-life impairments are highly prevalent among Yemeni cancer patients receiving chemotherapy. Education, lifestyle, and clinical factors significantly influence these outcomes, underscoring the need for tailored interventions and supportive care in resource-limited settings. These findings can guide policy and clinical practice by promoting routine screening and tailored supportive care in oncology settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.